Oncothyreon to present at upcoming investment conferences

BELLEVUE, WA, March 12 /CNW/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX:ONY), a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, today announced that Robert Kirkman, M.D., President and Chief Executive Officer, is scheduled to present at two upcoming investment conferences.

The first presentation is scheduled to take place at the Invest Northwest CEO and Investor Forum at 4:10 p.m. Pacific Time on March 18 in Seattle. The second presentation is scheduled to take place at the Cowen & Co. 28th Annual Health Care Conference at 10:15 a.m. Eastern Time on March 20 in Boston.

A live and archived webcast of Dr. Kirkman's presentation at the Cowen & Co. Conference will be webcast and can be accessed at www.oncothyreon.com under the "News & Events" section.

About Oncothyreon

Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit www.oncothyreon.com.